Alpha-Lipoic Acid (ALA)

DRUG3 trials

Sponsors

Eva Pharma, Ain Shams University, Minia University

Conditions

Anti Oxidative StressCisplatin NephrotoxicityLaparoscopic AppendectomyNephrotoxicityPain ManagementPolyneuropathy, Diabetic

Phase 2

Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity

RecruitingNCT07564479

Minia UniversityCisplatin Nephrotoxicity, Nephrotoxicity

Start: 2026-03-10End: 2027-06-01Target: 50Updated: 2026-05-04

Phase 4

Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt

CompletedNCT05813496

Eva PharmaPolyneuropathy, Diabetic

Start: 2022-10-26End: 2024-12-11Updated: 2025-03-25

Unknown Phase

Comparing N-Acetylcysteine (NAC) Versus Alpha-Lipoic Acid (ALA) as Adjuncts for Postoperative Pain Management After Laparoscopic Appendectomy

Not yet recruitingNCT07360379

Ain Shams UniversityAnti Oxidative Stress, Laparoscopic Appendectomy, Pain Management

Start: 2025-12-28End: 2026-05-01Target: 180Updated: 2026-01-22